CNBX Pharmaceuticals Inc.

CNBX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 1, 2026 CURRENT REPORT
SCHEDULE 13G/A Aug 14, 2026
10-Q Jun 24, 2026 FORM 10-Q FOR MAY 2026
SCHEDULE 13G/A May 8, 2026
10-Q Apr 14, 2026 FORM 10-Q
8-K Mar 17, 2026 FORM 8-K
SCHEDULE 13G/A Feb 5, 2026
10-Q Jan 14, 2026 QUARTERLY REPORT
10-K Dec 1, 2025 FORM 10-K FOR AUG 2025
SCHEDULE 13G/A Nov 10, 2025
SCHEDULE 13G/A Aug 13, 2025
10-Q Jul 14, 2025 FORM 10-Q
SCHEDULE 13G/A May 13, 2025
10-Q Apr 14, 2025 10-Q
SCHEDULE 13G/A Feb 13, 2025
8-K Jan 30, 2025 FORM 8-K
10-Q Jan 13, 2025 FORM 10-Q FOR NOV 2024
10-K Nov 29, 2024 FORM 10-K FOR AUGUST 2024
SC 13G/A Nov 14, 2024 SC 13G/A
10-Q Jul 15, 2024 FORM 10-Q
UPLOAD Jun 17, 2024
CORRESP Jun 6, 2024
UPLOAD May 30, 2024
CORRESP May 21, 2024
UPLOAD Apr 22, 2024
← Newer Page 1 of 13 · 301 filings Older →